Moreover, it will help identify patients with late-onset disease who are sometimes misdiagnosed with age-related macular degeneration who are at risk of being advised to take supplements containing high doses of vitamin A, which can have detrimental effects in STGD1/ABCA4R. The gene discussed is ABCA4; the disease is age-related macular degeneration.